BioBabraham Symposium

Last week at the BioBabraham Symposium, our CSO Andy Billinton shared how at Harness Therapeutics we're working to change the landscape for neurodegenerative disease treatment.

This event brought together companies and academics from across the Babraham Research Campus to share their latest scientific developments, growth stories, and examples of collaboration.

Andy's presentation on our approach to upregulating protein targets generated meaningful conversations about our bispecific ASOs and, crucially, how we ensure our innovations can actually reach patients who need them.